静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的效果观察

目的观察静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的临床应用效果。方法随机抽选于深圳市第二人民医院接受治疗的84例肺炎患儿,将其平均分成观察组与对照组(每组42例),分别给予两组患儿静脉滴注加雾化吸入沐舒坦与静脉滴注沐舒坦的方案进行治疗。结果观察组的血气指标改善程度大于对照组;观察组的各项临床症状消退时间与住院时间明显短于对照组的对应值;观察组的治疗总有效率为97.62%,明显高于对照组的85.71%,组间数据差异均具有统计学意义(P0.05)。结论给予新生儿肺炎幼儿实施静脉滴注加雾化吸入沐舒坦治疗方案,不仅能明显改善患儿的血气指标,缩短其症状消退时间与住院时间,也能显著提高患儿的治疗效果,降低不良反应的发生概率。

Intravenous Drip and Observe the Effect of Aerosol Inhalation of Ambroxol in the Treatment of Neonatal Pneumonia

Objective Intravenous infusion to observe the clinical effect of Mucosolvan aerosol inhalation in the treatment of neonatal pneumonia. Methods Stochastically 84 patients, and divided observation group and control group, were given intravenous injection and inhalation ambroxol and intravenous Mucosolvan treatment. Results The blood gas indexes, clinical symptoms subsided time, hospital stay and total effective rate in the observation group were all higher than those in the control group, and the difference between the groups was statistically significant ( P<0. 05 ) . Conclusion The intravenous drip with atomization inhalation of Mucosolvan, not only can significantly improve the patient’s blood gas index, shorten the symptoms subsided time and hospitalization time, also can reduce the probability of occurrence of adverse reactions.